We are live on ! Find out more
SIOX

Sio Gene Therapies Inc. Common Stock
SIOX

Delisted

SIOX was delisted on the 22nd of March, 2023.

Back to rankings

57 hedge funds and large institutions have $48.4M invested in Sio Gene Therapies Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 9

61% more capital invested

Capital invested by funds: $30M → $48.4M (+$18.4M)

7% less funds holding

Funds holding: 61 → 57 (-4)

13% less call options, than puts

Call options by funds: $434K | Put options by funds: $501K

27% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 15

Holders
57
Holders Change
-4
Holders Change %
-6.56%
% of All Funds
1.23%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
23
Reduced
9
Closed
15
Calls
$434K
Puts
$501K
Net Calls
-$67K
Net Calls Change
-$56K

Top Buyers

Rank Fund Capital Flow
1
CH
CVI Holdings
Delaware
+$7.09M
2
JG
Jefferies Group
New York
+$3.14M
3
Citadel Advisors
Citadel Advisors
Florida
+$2.11M
4
ECM
Endurant Capital Management
California
+$1.81M
5
Bank of America
Bank of America
North Carolina
+$1.72M

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.51M
2
SFM
Sphera Funds Management
Israel
-$3.85M
3
OM
Opaleye Management
Massachusetts
-$577K
4
HP
Hound Partners
New York
-$398K
5
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
-$340K
Name Holding Trade Value Shares
Change 		Change in
Stake
CH
1
CVI Holdings
Delaware
$8.16M +$7.09M +712,158 +1,291%
SFM
2
Sphera Funds Management
Israel
$6.79M -$3.85M -386,458 -38%
DM
3
Deerfield Management
New York
$5.28M -$7.51M -753,709 -60%
Renaissance Technologies
4
Renaissance Technologies
New York
$3.43M +$241K +24,250 +8%
JG
5
Jefferies Group
New York
$3.35M +$3.14M +315,218 New
Citadel Advisors
6
Citadel Advisors
Florida
$2.3M +$2.11M +212,178 +5,211%
BlackRock
7
BlackRock
New York
$2.16M +$308K +30,900 +18%
ECM
8
Endurant Capital Management
California
$1.93M +$1.81M +181,664 New
Bank of America
9
Bank of America
North Carolina
$1.84M +$1.72M +172,794 +1,919,933%
Hudson Bay Capital Management
10
Hudson Bay Capital Management
Connecticut
$1.76M +$93.4K +9,375 +6%
MIM
11
Monashee Investment Management
Massachusetts
$1.73M +$373K +37,500 +30%
Primecap Management
12
Primecap Management
California
$1.4M -$6.59K -662 -0.5%
GPCM
13
Granite Point Capital Management
Massachusetts
$1.37M +$1.29M +129,167 New
Adage Capital Partners
14
Adage Capital Partners
Massachusetts
$1.33M – – –
Millennium Management
15
Millennium Management
New York
$1.23M +$527K +52,952 +85%
Macquarie Group
16
Macquarie Group
Australia
$1.15M +$1.08M +108,125 New
BFM
17
Boothbay Fund Management
New York
$464K +$176K +17,681 +68%
Morgan Stanley
18
Morgan Stanley
New York
$291K +$238K +23,874 +680%
Marshall Wace
19
Marshall Wace
United Kingdom
$272K +$255K +25,609 New
GCP
20
GSA Capital Partners
United Kingdom
$263K +$51.4K +5,163 +26%
Goldman Sachs
21
Goldman Sachs
New York
$249K +$175K +17,611 +304%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$233K +$100K +10,083 +85%
Vanguard Group
23
Vanguard Group
Pennsylvania
$226K -$97.7K -9,807 -32%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$209K +$47.2K +4,738 +32%
CSS
25
Cubist Systematic Strategies
Connecticut
$145K +$136K +13,613 New
1
2 3

SIOX Hedge Fund Activity: Q1 2019 in Review

57 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Sio Gene Therapies Inc. Common Stock (SIOX) for Q1 2019, worth a combined $48.4M — up 61% from $30M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of SIOX and 11 opened new positions — a net loss of 4 holders — while 9 trimmed existing stakes and 23 added.

The largest buyer was CVI Holdings, adding an estimated $7.09M. The largest seller was Deerfield Management, cutting an estimated $7.51M.

  • 57 institutional investors held Sio Gene Therapies Inc. Common Stock (SIOX) as of Q1 2019, down from 61 in Q4 2018.
  • Funds reported $48.4M of Sio Gene Therapies Inc. Common Stock stock for Q1 2019, up 61% quarter-over-quarter.
  • 11 funds opened new Sio Gene Therapies Inc. Common Stock positions in Q1 2019 and 15 closed out, a net change of -4 holders.
  • The largest Sio Gene Therapies Inc. Common Stock buyer in Q1 2019 was CVI Holdings, an estimated $7.09M added.
  • The largest Sio Gene Therapies Inc. Common Stock seller in Q1 2019 was Deerfield Management, an estimated $7.51M sold.

Based on aggregated 13F filings for Q1 2019.